Tenofovir disoproxil
Tenofovir Disoproxil[edit]
Tenofovir disoproxil, marketed under the trade name Viread--- among others, is an antiviral medication primarily used in the treatment of chronic Hepatitis B and the prevention and treatment of HIV/AIDS.
Overview[edit]
Tenofovir disoproxil is often recommended for use in combination with other antiretrovirals. It plays a crucial role in HIV/AIDS management strategies and can be used in pre-exposure prophylaxis (PrEP) for individuals at high risk of HIV infection.
Usage in HIV/AIDS and Hepatitis B[edit]
For HIV/AIDS, Tenofovir disoproxil is part of the first-line treatment and can be used in various combination therapies. In chronic Hepatitis B, it helps to decrease the amount of virus in the body but is not a cure.
Pre-exposure Prophylaxis (PrEP)[edit]
As a part of PrEP, it is used to prevent HIV in people at high risk, including those with an HIV-positive partner and in situations like needlestick injuries.
Combination Therapies[edit]
Tenofovir disoproxil is often sold in combination with other medications, such as emtricitabine (as emtricitabine/tenofovir) and efavirenz/emtricitabine/tenofovir, enhancing its effectiveness.
Administration and Dosage[edit]
It is available orally as a tablet or powder. The dosage and administration depend on the condition being treated, the patient's overall health, and other factors.
Effectiveness and Limitations[edit]
While Tenofovir disoproxil is effective in managing HIV/AIDS and Hepatitis B, it does not cure these diseases. Regular monitoring and adherence to the treatment regimen are essential for its effectiveness.
Safety and Side Effects[edit]
Tenofovir disoproxil is generally well-tolerated but can have side effects, including kidney problems and bone loss. Patients should discuss potential risks with their healthcare provider.
See Also[edit]
External Links[edit]
References[edit]
| This article is a stub. You can help WikiMD by registering to expand it. |
